PFKM and colorectal carcinoma: has reported that upregulated expression of lncRNA MAFG-AS1 in CRC promotes cancer proliferation, cell cycle progression, and inhibits cell apoptosis by targeting the miR-147b/NDUFA4 axis to upregulate phosphofructokinase-1 (PFK-1) expression [77].